Lidds AB (FRA:5LD) EV-to-FCF: 1.99 (As of Jul. 02, 2026)


What is Lidds AB EV-to-FCF?

Lidds AB FRA:5LD EV-to-FCF is 1.99 as of Jul. 02, 2026. The stock has 2 warning signs investors should review.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lidds AB's Enterprise Value is €-0.71 Mil. Lidds AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was €-0.36 Mil. Therefore, Lidds AB's EV-to-FCF for today is 1.99.

The historical rank and industry rank for Lidds AB's EV-to-FCF or its related term are showing as below:

FRA:5LD' s EV-to-FCF Range Over the Past 10 Years
Min: -64   Med: -5.83   Max: 108.2
Current: 1.9

During the past 13 years, the highest EV-to-FCF of Lidds AB was 108.20. The lowest was -64.00. And the median was -5.83.

FRA:5LD's EV-to-FCF is not ranked
in the Biotechnology industry.
Industry Median: 15.57 vs FRA:5LD: 1.90

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-02), Lidds AB's stock price is €0.0002. Lidds AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was €-0.004. Therefore, Lidds AB's PE Ratio (TTM) for today is At Loss.


Lidds AB  (FRA:5LD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Lidds AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0002/-0.004
=At Loss

Lidds AB's share price for today is €0.0002.
Lidds AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Lidds AB EV-to-FCF Related Terms


Lidds AB EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Lidds AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lidds AB EV-to-FCF Chart

Lidds AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.89 -6.45 -1.58 0.23 -1.51

Lidds AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.39 -1.51 -1.46 -1.40 -1.83

FRA:5LD vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, Lidds AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lidds AB EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lidds AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lidds AB's EV-to-FCF falls into.



Lidds AB EV-to-FCF Calculation

Lidds AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-0.712/-0.358
=1.99

Lidds AB's current Enterprise Value is €-0.71 Mil.
Lidds AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of 1.99 mean?
Lidds AB (FRA:5LD) has a EV-to-FCF of 1.99 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Lidds AB and its competitors.
Is Lidds AB's EV-to-FCF too high?
Lidds AB's current EV-to-FCF is 1.99. The Biotechnology industry median EV-to-FCF is 15.57. Lidds AB's value of 1.99 is 87.2% below this industry median.
How does Lidds AB's EV-to-FCF compare to VRTX and REGN?
Lidds AB's EV-to-FCF of 1.99 can be compared against companies in the Biotechnology industry. The industry median EV-to-FCF is 15.57. Lidds AB's value of 1.99 is 87.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.57, based on 333 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lidds AB's current EV-to-FCF of 1.99 is 87.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Lidds AB and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lidds AB's current EV-to-FCF is 1.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lidds AB stock overvalued right now?
Lidds AB (FRA:5LD) has a current EV-to-FCF of 1.99. The current EV-to-FCF is 1.99 and 87.2% below the Biotechnology industry median of 15.57. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Lidds AB (FRA:5LD), the current EV-to-FCF is 1.99 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lidds AB Business Description

Address c/o Excore, Kungsportsavenyen 22, Goteborg, SWE, 411 36
Lidds AB is a Sweden-based drug delivery company focused on its proprietary NanoZolid technology platform. The NanoZolid system is used to formulate drugs for local administration with controlled and sustained release over extended periods. The company offers this technology to partners and is also developing its own pipeline of drug candidates, prominently in oncology, where the platform is used to enable localized and sustained drug delivery. It has a pipeline with several projects in clinical development, both in early- and late-stage clinical phases, and projects about to enter clinical development.